Each variant-therapy-drug association includes a clinical status of one of the following
case report
early trials
FDA-approved
FDA-rejected
late trials
NCCN guidelines
NCCN/ CAP guidelines
preclinical
I suspect these terms are too vague to be mapped to an ontology such as OCRE. Or we could make certain assumptions (early trials = Phase I, late trials = Phase 4?). As a starting point we can mint IDs in the CGD namespace. Requested by @bwalsh.
Each variant-therapy-drug association includes a clinical status of one of the following
case report early trials FDA-approved FDA-rejected late trials NCCN guidelines NCCN/ CAP guidelines preclinical
I suspect these terms are too vague to be mapped to an ontology such as OCRE. Or we could make certain assumptions (early trials = Phase I, late trials = Phase 4?). As a starting point we can mint IDs in the CGD namespace. Requested by @bwalsh.